Showing results (181-190 of 389) with videos related to

Sort By:
Pageof 39
Oncology and Therapy|July 14, 2026
A Comprehensive Mapping of Real-World Studies and Data Sources for Oncology in China: Insights into Landscape, Challenges, and Future DirectionYaqi Jia, Yanbing Li, Siyan Zhan, et al.
Oncology and Therapy|June 25, 2026
Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC): An Aggressive Disease Course and Limitations for Personalized OncologyCeline Oanæs, Herish Garresori, Dordi Lea, et al.
Oncology and Therapy|September 22, 2022
Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational StudyScott Paulson, David Ray, Sharan Aranha, et al.
Oncology and Therapy|January 8, 2025
Niraparib as First-Line Maintenance Therapy in Patients with Stage III Ovarian Cancer and No Visible Residual Disease: AR1ZE Real-World StudyDana M Chase, Maya Hanna, Jonathan T Lim, et al.
Oncology and Therapy|December 19, 2024
Experience and Care Pathway of Patients with Lung Cancer: An Online International SurveyPauline Frank, Julie Laurent, Lorraine Dallas, et al.
Oncology and Therapy|November 21, 2024
The State of the Art of Image Guided Superficial Radiation Therapy Treatment of Non-melanoma Skin Cancer in Outpatient Dermatology Clinics in the United States and Review of the LiteraturePeyton M Harris, Aaron S Farberg, Janine Hopkins, et al.
Oncology and Therapy|November 14, 2025
Two-Stage Estimation of Overall Survival in the Phase 3 CheckMate 9ER Trial, Adjusting for the Impact of Subsequent TherapyMarc-Oliver Grimm, Emma Karim, Venediktos Kapetanakis, et al.
Oncology and Therapy|November 15, 2025
Cost-effectiveness of Nivolumab + Platinum Doublet Chemotherapy as Neoadjuvant Treatment for Resectable Non-Small Cell Lung Cancer in EnglandJoel Russell, Mack Harris, Ariel Sun, et al.
Oncology and Therapy|October 15, 2025
Overlapping Extremes: An Analysis of Avelumab Maintenance and Pembrolizumab in Advanced Urothelial CarcinomaMartina Catalano, Irene de Gennaro Aquino, Ismaela Anna Vascotto, et al.
Oncology and Therapy|October 2, 2025
Abemaciclib Persistence in Patients with HR+, HER2-, Node-Positive Early Breast Cancer: a Real-World AnalysisKathryn Hudson, Wambui Gathirua-Mwangi, Lindsay A Williams, et al.
Pageof 39